| Identification | Back Directory | [Name]
2H-3-Benzazepin-2-one, 3-[[(3S)-1-[2-(3,4-dimethoxyphenyl)ethyl]-3-piperidinyl]methyl]-1,3,4,5-tetrahydro-7,8-dimethoxy- | [CAS]
147541-45-5 | [Synonyms]
2H-3-Benzazepin-2-one, 3-[[(3S)-1-[2-(3,4-dimethoxyphenyl)ethyl]-3-piperidinyl]methyl]-1,3,4,5-tetrahydro-7,8-dimethoxy- | [Molecular Formula]
C28 H38 N2 O5 | [MOL File]
147541-45-5.mol | [Molecular Weight]
482.61 |
| Hazard Information | Back Directory | [Uses]
Cilobradine (Cilo) is a HCN channel blocker with heart rate reducing activity. Cilobradine blocks the slow inward current of human HCN1, HCN2, HCN3, and HCN4 channels. Cilobradine has a slightly higher efficiency in blocking endogenous If in mouse sinoatrial node cells (IC50 value is 0.62μM). Cilobradine can dose-dependently reduce the heart rate from 600 to 200 bpm with an ED50 value of 1.2 mg/kg. Cilobradine induces arrhythmias at doses greater than 5 mg/kg, which are characterized by periodic fluctuations between T waves and P waves[1]. | [References]
[1] Bradycardic and proarrhythmic properties of sinus node inhibitors |
|
|